Zobrazeno 1 - 10
of 160
pro vyhledávání: '"Che-Kai Tsao"'
Autor:
Qian Qin, Tomi Jun, Bo Wang, Vaibhav G. Patel, George Mellgard, Xiaobo Zhong, Mahalya Gogerly-Moragoda, Anish B. Parikh, Amanda Leiter, Emily J. Gallagher, Parissa Alerasool, Philip Garcia, Himanshu Joshi, MBBS, Matthew Galsky, William K. Oh, Che-Kai Tsao
Publikováno v:
Discover Oncology, Vol 13, Iss 1, Pp 1-11 (2022)
Abstract Objectives Response to immune checkpoint inhibitor (ICI) remains limited to a subset of patients and predictive biomarkers of response remains an unmet need, limiting our ability to provide precision medicine. Using real-world data, we aimed
Externí odkaz:
https://doaj.org/article/37da49ca41554ae38f0bb80d40f404bf
Publikováno v:
Journal of Kidney Cancer and VHL, Vol 8, Iss 4 (2021)
Advance diagnostic and treatment modalities have improved outcomes for renal cell carcinoma (RCC) patients, but the prognosis for those with metastatic disease (mRCC) remains poor. As given metastatic distribution is critical in guiding treatment dec
Externí odkaz:
https://doaj.org/article/95c76cf3ac5a4abb9018b1464cf150d1
Autor:
Sudeh Izadmehr, Dara J. Lundon, Nihal Mohamed, Andrew Katims, Vaibhav Patel, Benjamin Eilender, Reza Mehrazin, Ketan K. Badani, John P. Sfakianos, Che-Kai Tsao, Peter Wiklund, William K. Oh, Carlos Cordon-Cardo, Ashutosh K. Tewari, Matthew D. Galsky, Natasha Kyprianou
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Coronavirus disease–2019 (COVID-19), a disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, has become an unprecedented global health emergency, with fatal outcomes among adults of all ages throughout the world.
Externí odkaz:
https://doaj.org/article/e4f97be1ff14433f99ef56e3923b0268
Publikováno v:
Cells, Vol 10, Iss 11, p 3231 (2021)
Immunotherapy has revolutionized the treatment landscape for many cancer types. The treatment for renal cell carcinoma (RCC) has especially evolved in recent years, from cytokine-based immunotherapies to immune checkpoint inhibitors. Although clinica
Externí odkaz:
https://doaj.org/article/951e1e7f7a2f46bbb26efa30f2a3f187
Autor:
Katherine Brewer, Kyrollis Attalla, Fatima Husain, Che-Kai Tsao, Ketan K. Badani, John P. Sfakianos
Publikováno v:
Urology Case Reports, Vol 9, Iss C, Pp 33-36 (2016)
Primary leiomyosarcomas of the inferior vena cava (IVC) are rare tumors associated with poor prognosis, and surgical resection with the goal of obtaining negative margins is the gold standard for initial treatment. Tumor characteristics of both extra
Externí odkaz:
https://doaj.org/article/e092285024464f41a2247876e4cfdcfb
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 9 (2017)
Renal cell cancer (RCC) continues to be among the most lethal malignancies in the USA. Introduction of anti-vascular epidermal growth factor receptor tyrosine kinase inhibitors over a decade ago resulted in improvement in disease outcomes, but furthe
Externí odkaz:
https://doaj.org/article/19b59a089c6548b5b2b29fb516efda2f
Publikováno v:
Therapeutic Advances in Urology, Vol 6 (2014)
For decades, cytotoxic therapy was considered ineffective for the treatment of metastatic castration-resistant prostate cancer (mCRPC). Earlier therapies such as estramustine and mitoxantrone received regulatory approval based upon improvement in pal
Externí odkaz:
https://doaj.org/article/ebac16219e494239830352945a0192d3
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 5 (2011)
Castration resistant prostate cancer has historically been considered chemotherapy insensitive. However, the approval of estramustine phosphate, mitoxantrone, and docetaxel, over the past few decades, has challenged this notion. Despite these advance
Externí odkaz:
https://doaj.org/article/01bc46bf52a44bc3a5e6747132c8d723
Autor:
Mellgard, George, Saffran, Nathaniel, Chakrani, Zakaria, McCroskery, Stephen, Taylor, Nicole, Patel, Mann, Liaw, Bobby, Galsky, Matthew, Oh, William, Che-Kai Tsao, Patel, Vaibhav
Publikováno v:
American Journal of Clinical Oncology; Oct2024, Vol. 47 Issue 10, p459-464, 6p
Autor:
Fionnuala Crowley, Meredith Mihalopoulos, Simita Gaglani, Ashutosh K. Tewari, Che-Kai Tsao, Miroslav Djordjevic, Natasha Kyprianou, Rajveer S. Purohit, Dara J. Lundon
Publikováno v:
British Journal of Cancer. 128:177-189
Transgender individuals represent 0.55% of the US population, equivalent to 1.4 million transgender adults. In transgender women, feminisation can include a number of medical and surgical interventions. The main goal is to deprive the phenotypically
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a248a161f7cd5f8afd42d26ce1c0aab
https://doi.org/10.1038/s41416-022-01989-y
https://doi.org/10.1038/s41416-022-01989-y